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Abstract
Background Prior abdominal surgery increases complexity of abdominal operations. Effort to prevent injury during
adhesiolysis might result in less extensive bowel resection in colorectal cancer surgery. The aim of this study was to
evaluate the effect of prior abdominal surgery on the outcome of colorectal cancer surgery.
Methods A nationwide prospective database of patients with primary colorectal cancer resection in The Netherlands
between 2010 and 2012 was reviewed for histopathology, morbidity and mortality in patients with compared to
patients without prior abdominal surgery.
Results 9042 patients with and 17,679 without prior abdominal surgery were analyzed. After prior abdominal
surgery 20.7 % had less than 10 lymph nodes in the histopathological specimen compared to 17.8 % without prior
abdominal surgery (adjusted OR 1.17, 95 % CI 1.09–1.26). Adjusted ORs for less than 10 and 12 lymph nodes were
significant in colon cancer resection and not in rectal cancer resection. Subgroups of patients who had previous
hepatobiliary surgery or other abdominal surgery had a higher incidence of inadequate number of harvested lymph
nodes. Prior colorectal surgery increased the percentage of positive circumferential rectal resection margin by 64 %
(12.5 and 7.6 %; adjusted OR 1.70, 95 % CI 1.21–2.39). For colon cancer morbidity was significantly higher in
patients with prior surgery (33.2 and 29.7 %; adjusted OR 1.18, 95 % CI 1.10–1.26), 30-day mortality was com-
parable (4.7 % prior surgery and 3.8 % without prior surgery; adjusted OR 1.01, 95 % CI 0.88–1.17).
Conclusions Prior abdominal surgery compromises the quality of resection and increases postoperative morbidity in
patients with primary colorectal cancer.
Introduction
Prior abdominal surgery increases the complexity and
morbidity of abdominal operations, mainly due to the fre-
quent presence of postoperative intra-abdominal adhesions
[1]. The incidence of postoperative intra-abdominal adhe-
sions after previous surgery ranges between 67 and 95 %
[2–5]. Adhesions may necessitate adhesiolysis, which is
time consuming and results in full-thickness or seromus-
cular bowel injury in one-third of the patients [6]. Adhe-
siolysis and associated bowel injury increase morbidity and
mortality [6, 7]. The cautious approach to the bowel during
adhesiolysis to avoid injury, might compromise access to
the operative field and extent of bowel resection, with
possibly smaller or even incomplete resection margins.
When access to the pelvic area for performing rectal
resection is difficult due to a previous operation, care is
taken not to injure ureters or main vessels and nerves,
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possibly limiting mesorectal excision. A small resection
margin, has been identified as a risk factor for poor lymph
node harvest [8]. Minimal information is available
regarding the effect of previous surgery on quality of
resection margin or number of lymph nodes. Two retro-
spective studies showed no difference in number of har-
vested lymph nodes and resection margin [9, 10]. Both
studies comprised low numbers of patients (n = 86 and
n = 267), and both reported overall mean number of har-
vested lymph nodes less than 10. This low number possibly
reflects inadequate surgical resection or inadequate quality
of histopathological examination of the specimen.
Since 2009 the Dutch Surgical Colorectal Audit (DSCA)
database is in use to assess and benchmark outcomes of
colorectal cancer treatments between hospitals. Prior sur-
gery is one of the many variables recorded in this database.
This gave us the opportunity to evaluate the effect of prior
abdominal surgery on the outcome of colorectal cancer
surgery in more than 25 000 Dutch patients with respect to
histopathological quality of resection and postoperative
morbidity and mortality.
Patients and methods
DSCA
Data were retrieved from the dutch surgical colorectal audit
(DSCA), which was initiated by the Dutch Surgical Society
to monitor and improve the quality of surgical care in
colorectal cancer patients on a national level. The DSCA
contains data on primary colorectal cancer resections reg-
istered by all 92 Dutch hospitals performing colorectal
cancer surgery as from 2009 [11]. Recurrent colorectal
cancer patients are not included in the database. The
dataset shows a high level of completeness on most items
and a case ascertainment of approximately 95 % when
compared with the Netherlands Cancer Registry [12].
Details of the dataset regarding data collection and
methodology have been published elsewhere [11]. Medical
ethics committee approval was not required for this study
as all patients and hospital information in the DSCA were
anonymous.
In-and exclusion criteria
All patients aged 18 years and older who underwent
colonic and rectal cancer resection in the Netherlands
between January 2010 and December 2012 were included
in this study. Patients who underwent a transanal procedure
were excluded from analysis.
Outcomes
Primary outcome measures were number of harvested
lymph nodes, circumferential rectal resection margin
(CRM), CRM positivity, and completeness of resection in
colon cancer. The CRM was considered positive if tumor
cells were within 1 mm of the resection margin. Com-
pleteness of resection was defined as complete resection
(resection with margins free of disease at histopathology,
R0) or incomplete resection (margins positive for disease at
histopathology, R1 or R2). R1 and R2 were taken together
because of relatively small patient numbers with incom-
plete resection. Besides absolute number of harvested
lymph nodes we used cut-offs of 10 and 12 lymph nodes.
These are the cut-offs of the Dutch and US guidelines [13,
14]. Secondary outcome measures were postoperative
complications and 30-day mortality.
Potential risk factors for adverse oncological or clinical
outcome, including patient factors (age, sex, body mass index
(BMI), ASA fitness grade, previous abdominal surgery),
tumor factors (stage, location, preoperative tumor compli-
cations) and treatment factors (neoadjuvant therapy, type of
surgical resection, operation technique, urgency of surgery,
extent of resection), were extracted from the database. There
is no information regarding adhesions in the database (e.g.,
incidence or severity of adhesions or adhesiolysis time).
Statistical analysis
Univariable analyses were carried out to examine the
association previous abdominal surgery and number of
harvested lymph nodes, CRM, CRM positivity, complete-
ness of resection, postoperative complications, and 30-day
mortality. Multivariable logistic regression analyses were
performed to correct for possible confounders. A manual
stepwise model was used, with inclusion of variables with
P \ 020. Clinically relevant variables, i.e., neoadjuvant
therapy, were added to the statistical model. Conversion
from laparoscopic to open technique and tumor localization
were not included in the multivariate analysis because of
the collinearity between prior operations and conversion,
and between localization of the primary tumor and type of
resection. Type of resection is highly influenced by the
localization of the primary tumor, but the type of resection
has a larger influence on clinical and histopathological
outcome, especially in case of synchronous tumors.
Subgroup analysis regarding number of lymph nodes
and percentage of resections with less than 10 and 12
lymph nodes was performed for colon and rectal cancer
separately. Number of lymph nodes after colon and rectal
cancer resection, percentage of colon and rectal cancer
resections with less than 10 and 12 lymph nodes, incom-
plete colon cancer resection and CRM and CRM positivity
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Table 1 Baseline characteristics Cohort 2010–2012
Prior abdominal operations Yes (N = 9042) No (N = 17,679) P Value
Age 71.3 (±10.8) 68.4 (±11.3) \0.001
Sex (%) 41.9 % male 61.3 % male \0.001
ASA (%)
I 15.5 23.0 \0.001
II 58.2 55.1
III 24.8 20.0
IV 1.5 1.8
V 0.1 0.1
Urgency operation (%)
Elective 85.9 83.8 \0.001
Elective after stent placement 0.7 0.6
Urgent 7.4 8.0
Emergency 5.9 7.5
Unknown 0.2 0.1
Tumor localization (%)
Caecum 15.9 13.3 \0.001
Appendix 0.8 0.4
Ascending colon 14.6 12.4
Hepatic flexure 4.8 4.4
Transverse colon 6.6 5.0
Splenic flexure 2.3 2.4
Descending colon 4.7 4.3
Sigmoid colon 25.3 28.8
Rectum 24.9 29.0
Neoadjuvant Therapy (%) (rectal cancer, N = 6457) N = 1921 N = 4536 0.26
No 3.4 2.7
Short course 55.2 54.1
Long course 5.9 5.8
Chemoradiation 35.5 37.4
Operation technique (%)
Open 60.6 54.2 \0.001
Laparoscopic 39. 4 45.8
Conversion in laparoscopy (n = 8589) (%)
No 76.5 82.6 \0.001
Early (\30 min) 12.5 8.5
Late ([30 min) 11.1 9.0
Reason for conversion %
(N = 1406) \0.001
Advanced tumor 14.3 26.9
Accessibility 79.1 65.4
Peroperative complication 6.7 7.7
Type of resection %
Ileocaecal 1.1 0.9 \0.001
Resection/appendicectomy 36.1 30.7
Right hemicolectomy 2.7 1.9
Transverse colectomy 7.8 7.7
Left hemicolectomy 40.6 47.3
(Low)Anterior 1.7 1.4
Resection/sigmoidectomy 7.6 8.5
Subtotal colectomy 0.8 0.6
Abdominoperineal Resection 1.4 1.0
Proctocolectomy
Other
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were analyzed in subgroups of different types of abdominal
surgery in history as defined in the database: colorectal surgery
(including appendectomy), urogenital surgery, hepatobiliary
surgery (including cholecystectomy), upper gastrointestinal
surgery (including pancreatic surgery), or other abdominal
surgery not otherwise specified. These subgroups of previous
surgery were analyzed because reported incidences of adhe-
sion-related and adhesiolysis-related complications differ
between different anatomical locations of prior surgery [2, 15].
This subgroup analysis was performed in the cohort
2011–2012, because of a high level of missing data on location
of prior surgery in patients operated in 2010. Subgroup analysis
by magnitude of the previous operation was not possible
because this item is not registered in the database.
Results are reported as odds ratios with 95 % confidence
intervals. All data were analyzed using SPSS for Windows
version 20.0 software (SPSS, Chicago, IL). We excluded
per analysis those cases with missing data.
Results
27,341 Colorectal cancer patients were included in the
database from 2010 to 2012. After excluding patients
younger than 18 years (n = 17), transanal procedures
(n = 344), and patients with missing data of prior
abdominal surgery (n = 259), 26,721 patients were eligible
for inclusion. 9042 Patients (33.8 %) had undergone one or
more previous abdominal operations,17,679 patients
(66.2 %) had no prior abdominal surgery.
Baseline characteristics
Baseline characteristics for the groups with and without
prior abdominal surgery are presented in Table 1. All data
significantly differed between groups due to large patient
numbers. Clinically relevant differences were found for age
and sex. Mean age was 71.3 in the prior abdominal surgery
group compared to 68.4 in the no prior abdominal surgery
group. The prior abdominal surgery group comprised
41.9 % male patients compared to 61.3 % in the no prior
abdominal surgery group.
Histopathological and clinical outcome
Mean number of lymph nodes in the histopathology spec-
imen was 15.2 in the group with and 15.6 in the group
without prior abdominal surgery (Table 2). Number of
lymph nodes was less than 10 and 12 in 20.7 and 35.8 % of
patients with prior abdominal surgery compared to 17.8
and 32.8 % in patients without prior abdominal surgery.
For colonic resection the percentage of patients with less
than 10 and 12 lymph nodes was higher in the prior surgery
compared to the no prior surgery group. For rectal resection
differences were not significant after adjustment for other
variables (Table 2). No differences were found in com-
pleteness of colonic resection, mean circumferential rectal
resection margin and CRM positivity.
There was a small but significant increase in percentage
of patients with postoperative complications after prior
surgery (34.5 and 32.1 %; adjusted OR 1.14 (95 % CI
1.07–1.21). For colonic resection the percentage of patients
with complications was higher in the prior surgery com-
pared to the no prior surgery group. For rectal resection no
differences was found (Table 2). 30-day mortality was 0.9
percent higher in patients with (4.7 %) compared to those
without prior abdominal surgery (3.8 %). This difference
was not significant after adjustment for other variables.
Histopathological outcome by type of prior
operation
Histopathological results divided by type of prior abdom-
inal surgery, i.e., colorectal surgery, urogenital surgery,
Table 1 continued
Prior abdominal operations Yes (N = 9042) No (N = 17,679) P Value
T stage (pathol) (%)
1 7.1 6.1 0.001
2 20.8 19.6
3 55.7 57.6
4 13.0 13.5
X 2.1 1.8
0 1.3 1.4
N stage (pathol) %
0 60.3 57.5 \0.001
1 24.3 25.4
2 13.8 16.1
X 1.6 1.0
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hepatobiliary surgery, upper gastrointestinal surgery and
other abdominal operations are shown in Table 3 for
colonic resection and in Table 4 for rectal resection. Prior
upper gastrointestinal and urogenital operations did not
compromise the quality of oncological resection as reflec-
ted by number of lymph nodes, resection margins and
completeness of resection, for both colonic and rectal
resections. Prior colorectal resection significantly
decreased the number of lymph nodes in colon specimens.
There was a trend towards a higher percentage of patients
with less than 12 lymph nodes in the specimen (28.9 vs
25.5 %, P = 0.058). An almost two-third increase in
patients with CRM positivity of rectal specimens was
found (12.5 % prior colorectal resection and 7.6 no prior
colorectal resection). Prior hepatobiliary surgery and prior
other abdominal surgery were associated with increased
percentages of patients with less than 10 lymph nodes by
24 and 26, respectively, for colonic resection. For rectal
resection, prior hepatobiliary surgery increased the per-
centage of patients with less than 12 lymph nodes by 21.
No significant effects of other abdominal surgery were
found for rectal resections (Table 4).
Discussion
Prior abdominal surgery jeopardizes subsequent abdominal
surgical procedures. In the large Dutch Surgical Colorectal
Cancer Audit (DSCA) prospective database of colorectal
cancer patients increased postoperative complications were
demonstrated after prior abdominal surgery. More impor-
tantly, prior abdominal surgery had negative effects on
histopathological outcome parameters. A higher risk of
inadequate numbers of harvested lymph nodes was
demonstrated for colonic resections. Prior colorectal sur-
gery was associated with an almost two-third increase of
positive circumferential resection margins in rectal cancer
patients.
Results of the present study are in agreement with an
earlier report of a higher morbidity rate after repeat surgery
[6]. In a case-matched study of laparoscopic intestinal
resection even a doubling of the incidence of postoperative
complications was found after previous midline laparo-
tomy [1]. The DSCA database does not contain information
on the extent of prior operations, but only a gross differ-
entiation of anatomical locations where patients had their
Table 2 Histopathological and clinical outcome, cohort 2010–2012
Prior abdominal
operations N = 8949b
No prior abdominal
operations N = 17,534b
Crude OR/mean
difference (95 % CI)
Adjusted OR/mean
difference (95 % CI)a
Number of lymph nodes 15.2 15.6 0.39 (0.11–0.66)* 0.37 (0.14–0.60)*
Colon cancer 16.1 16.6 0.55 (0.200.90)* 0.43 (0.15–0.71)*
Rectal cancer 12.5 13.0 0.46 (0.11–0.81)* 0.14 (-0.23 to 0.50)
\10 Lymph nodes (% pts) 20.7 17.8 1.20 (1.13–1.28)* 1.17 (1.09–1.26)*
Colon cancer 16.5 13.4 1.28 (1.18–1.39)* 1.22 (1.11–1.33)*
Rectal cancer 32.9 28.7 1.22 (1.10–1.36)* 1.09 (0.96–1.23)
\12 Lymph nodes (% pts) 35.8 32.8 1.14 (1.08–1.20)* 1.10 (1.04–1.17)*
Colon cancer 30.7 27.6 1.16 (1.09–1.24)* 1.10 (1.02–1.18)*
Rectal cancer 50.8 45.6 1.23 (1.11–1.36)* 1.11 (0.99–1.24)
Incomplete resection colon
cancer (% pts)
3.3 3.8 0.87 (0.73–1.02) 0.92 (0.77–1.11)
Circumferential rectal
resection margin (mm)
11.0 11.1 0.111 (-0.56 to 0.77) 0.10 (-0.82 to 1.02)
CRM positivity (% pts) 10.2 9.1 1.14 (0.94–1.38) 1.12 (0.90–1.40)
Complications (% pts) 34.5 32.1 1.11 (1.05–1.17)* 1.14 (1.07–1.21)*
Colon cancer 33.2 29.7 1.17 (1.10–1.25)* 1.18 (1.10–1.26)*
Rectal cancer 38.0 37.9 1.01 (0.91–1.11) 1.04 (0.92–1.17)
30-day Mortality (% pts) 4.7 3.8 1.24 (1.09–1.40)* 1.01 (0.88–1.17)
Colon cancer 5.3 4.3 1.24 (1.08–1.42)* 1.01 (0.86–1.18)
Rectal cancer 2.7 2.6 1.04 (0.76–1.41) 1.02 (0.70–1.47)
* P\ 0.05
a Adjusted for male sex, age, ASA fitness grade, type of surgical resection, T stage at histopathology, N stage at histopathology, urgency of
surgery, operation technique and neoadjuvant chemotherapy
b Missing data excluded per analysis
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previous abdominal surgery. It is likely that the prior
abdominal surgery group partly consists of laparoscopic or
minor surgical procedures such as appendectomy and
cholecystectomy, which may account for the relatively
small effect on postoperative morbidity found in the pre-
sent study.
Two small retrospective series demonstrated no impact
of prior abdominal surgery on histopathological outcome
parameters in colorectal cancer. The number of lymph
nodes in colon specimens resected via minilaparotomy was
similar between 76 patients with prior abdominal surgery
and 187 patients without prior surgery [10]. Comparison of
Table 3 Histopathological outcome after colon cancer surgery according to type of prior abdominal surgery, cohort 2011–2012
Prior colorectal
operations
N = 1832b
No prior abdominal
operations
N = 10,404b
Crude OR/mean
difference (95 % CI)
Adjusted OR/mean
difference (95 % CI)a
Number of lymph nodes 16.3 17.1 0.80 (0.33–1.27)* 0.61 (0.14–1.08)*
\10 lymph nodes (% pts) 14.2 11.9 1.23 (1.06–1.42)* 1.11 (0.94–1.30)
\12 lymph nodes (% pts) 28.9 25.5 1.19 (1.06–1.33)* 1.12 (1.00–1.27)**
Incomplete resection (% pts) 6.2 3.8 1.66 (1.14–2.42)* 1.30 (0.90–1.89)
Prior urogenital
operations
N = 1790b
No prior abdominal
operations
N = 10,440b
Crude OR/mean
difference (95 % CI)
Adjusted OR/mean
difference (95 % CI)a
Number of lymph nodes 16.8 17.0 0.23 (-0.24 to 0.71) 0.25 (-0.25 to 0.74)
\10 Lymph nodes (% pts) 13.0 12.1 1.08 (0.93–1.26) 1.09 (0.92–1.29)
\12 Lymph nodes (% pts) 25.9 26.1 0.99 (0.88–1.11) 0.97 (0.86–1.10)
Incomplete resection (% pts) 3.3 3.6 0.91 (0.68–1.20) 1.03 (0.76–1.39)
Prior hepatobiliary
operations
N = 922b
No prior abdominal
operations
N = 11,317b
Crude OR/mean
difference (95 % CI)
Adjusted OR/mean
difference (95 % CI)a
Number of lymph nodes 16.2 17.0 0.77 (0.13–1.40)* 0.40 (-0.24 to 1.03)
\10 Lymph nodes (% pts) 14.9 12.0 1.28 (1.06–1.54)* 1.28 (1.04–1.58)*
\12 Lymph nodes (% pts) 28.2 25.9 1.12 (0.97–1.30) 1.09 (0.92–1.28)
Incomplete resection (% pts) 3.7 3.5 1.04 (0.73–1.49) 1.15 (0.78–1.71)
Prior upper gastrointestinal
operations
N = 200b
No prior abdominal
operations
N = 10,928b
Crude OR/mean
difference (95 % CI)
Adjusted OR/mean
difference (95 % CI)a
Number of lymph nodes 21.7 17.0 -4.68 (-6.58 to -2.78) -0.25 (-1.60 to 1.11)
\10 Lymph nodes (% pts) 16.0 12.0 1.40 (0.95–2.05) 1.13 (0.74–1.73)
\12 Lymph nodes (% pts) 28.0 25.9 1.11 (0.82–1.52) 0.91 (0.65–1.27)
Incomplete resection (% pts) 3.3 3.6 0.94 (0.44–2.00) 1.08 (0.45–2.58)
Prior other abdominal
operations
N = 815b
No prior abdominal
operations
N = 11,296b
Crude OR/mean
difference (95 % CI)
Adjusted OR/mean
difference (95 % CI)a
Number of lymph nodes 16.7 17.0 0.28 (-0.39 to 0.95) 0.12 (-0.55 to 0.79)
\10 Lymph nodes (% pts) 15.1 12.0 1.30 (1.06–1.59)* 1.28 (1.02–1.59)*
\12 Lymph nodes (% pts) 29.2 25.8 1.18 (1.01–1.38)* 1.16 (0.98–1.37)
Incomplete resection (% pts) 3.7 3.6 1.04 (0.71–1.53) 1.06 (0.71–1.60)
a Adjusted for male sex, age, ASA fitness grade, type of surgical resection, T stage at histopathology, N stage at histopathology, urgency of
surgery, operation technique and neoadjuvant chemotherapy
b Missing data excluded per analysis
* P\ 0.05
** P = 0.058
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Table 4 Histopathological outcome after rectal cancer surgery according to type of prior abdominal surgery, cohort 2011–2012
Prior colorectal
operations
N = 588b
No prior abdominal
operations
N = 3654b
Crude OR/mean
difference (95 % CI)
Adjusted OR/mean
difference (95 % CI)a
Number of lymph nodes 12.8 13.3 0.42 (-0.19 to 1.03) 0.22 (-0.41 to 0.85)
\10 lymph nodes (% pts) 30.4 26.2 1.23 (1.02–1.49)* 1.11 (0.89–1.38)
\12 lymph nodes (% pts) 47.4 43.9 1.15 (0.97–1.37) 1.03 (0.84–1.25)
Circumferential margin (mm) 10.0 10.8 0.83 (-0.12 to 1.77) 0.64 (-0.37 to 1.65)
CRM positivity (% pts) 12.5 7.6 1.74 (1.29–2.33)* 1.70 (1.21–2.39)*
Prior urogenital
operations
N = 531b
No prior abdominal
operations
N = 3711b
Crude OR/mean difference
(95 % CI)
Adjusted OR/mean
difference (95 % CI)a
Number of lymph nodes 12.7 13.3 0.56 (-0.08 to 1.21) 0.22 (-0.49 to 0.93)
\10 lymph nodes (% pts) 29.2 26.5 1.14 (0.94–1.40) 1.00 (0.78–1.28)
\12 lymph nodes (% pts) 48.2 43.8 1.19 (1.00–1.43) 1.13 (0.91–1.41)
Circumferential margin (mm) 12.1 10.5 -1.59 (-2.60 to -0.59) * -1.80 (-2.95 to -0.65) *
CRM positivity (% pts) 5.2 8.7 0.58 (0.37–0.90) 0.71 (0.44–1.16)
Prior hepatobiliary
operations
N = 271b
No prior abdominal
operations
N = 3965b
Crude OR/mean
difference (95 % CI)
Adjusted OR/mean
difference (95 % CI)a
Number of lymph nodes 12.5 13.3 0.76 (-0.11 to 1.63) 0.59 (-0.29 to 1.47)
\10 Lymph nodes (% pts) 32.1 26.5 1.31 (1.01–1.71)* 1.21 (0.90–1.63)
\12 Lymph nodes (% pts) 53.1 43.8 1.45 (1.14–1.86)* 1.32 (1.01–1.74)*
Circumferential margin (mm) 9.9 10.8 0.83 (-0.47 to 2.14) 0.60 (-0.78 to 1.98)
CRM positivity (% pts) 6.1 8.4 0.71 (0.42–1.21) 0.53 (0.28–1.01)
Prior upper gastrointestinal
operations
N = 81b
No prior abdominal
operations
N = 3785b
Crude OR/mean
difference (95 % CI)
Adjusted OR/mean
difference (95 % CI)a
Number of lymph nodes 14.2 13.3 -0.91 (-2.46 to 0.65) -1.13 (-2.70 to 0.44)
\10 Lymph nodes (% pts) 21.0 26.2 0.75 (0.44–1.28) 0.63 (0.34–1.18)
\12 Lymph nodes (%) 35.8 43.8 0.72 (0.45–1.13) 0.67 (0.40–1.12)
Circumferential margin (mm) 12.2 10.9 -1.36 (-3.88 to 1.15) -1.55 (-4.21 to 1.11)
CRM positivity (% pts) 10.6 7.7 1.43 (0.64–3.15) 1.62 (0.70–3.77)
Prior other abdominal
operations
N = 316b
No priorabdominal
operations
N = 3885b
Crude OR/mean
difference (95 % CI)
Adjusted OR/mean
difference (95 % CI)a
Number of lymph nodes 13.0 13.2 0.25 (-0.56 to 1.06) 0.28 (-0.57 to 1.13)
\10 Lymph nodes (% pts) 27.5 26.7 1.04 (0.81–1.35) 1.09 (0.81–1.48)
\12 Lymph nodes (% pts) 44.9 44.2 1.03 (0.82–1.30) 0.98 (0.75–1.28)
Circumferential margin (mm) 11.3 10.7 -0.68 (-1.93 to 0.57) -0.68 (-2.06 to 0.69)
CRM positivity (%) 9.4 8.2 1.73 (1.29–2.31)* 1.44 (0.89–2.36)
a Adjusted for male sex, age, ASA fitness grade, type of surgical resection, T stage at histopathology, N stage at histopathology, urgency of
surgery, operation technique and neoadjuvant chemotherapy
b Missing data excluded per analysis
* P\ 0.05
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lymph node numbers and resection margins after laparo-
scopic colorectal resection in 16 patients with and 44
patients without previous abdominal surgery also revealed
no differences [9]. These different results can be explained
by the small number of patients included in both studies.
The low mean number of lymph nodes, in both studies less
than 10, raises doubts about the quality of surgery or
histopathological examination.
Multiple studies have been published evaluating risk
factors for circumferential margin positivity in rectal can-
cer surgery. Well recognized risk factors for increased
CRM positivity are higher T and N stage, male sex and
absence of preoperative chemoradiation [16–19]. Prior
abdominal surgery has never been taken into account in
previous studies. Since the mesorectal fascia is a
retroperitoneal plane, CRM will not be directly affected by
intraperitoneal adhesions. However, when the lower
abdomen has been explored before surgeons can experi-
ence difficulty gaining access to the pelvis. The association
of prior colorectal surgery with increase in positive CRM is
therefore most likely explained by more challenging sur-
gery and compromised access to the pelvic area due to
intraperitoneal adhesions.
The major strength of this study is the use of a very large
prospective, complete and validated dataset. However,
there are limitations, because the database does not contain
descriptions of the presence or severity of adhesions, nor
whether adhesiolysis was performed during surgery.
Adhesiolysis has demonstrated to increase morbidity and
mortality in previous studies [6, 7] and adhesions as a
factor for a lower quality of colorectal resection specimens
is suggested given the significant findings for prior surgery.
The effect of postoperative adhesions on histopathological
outcome might even have been underestimated, because a
small portion of patients with prior abdominal surgery do
not have adhesions [2–5]. On the other hand, intra-ab-
dominal adhesions also occur in patients without prior
abdominal surgery. However, the incidence of these
adhesions is less than 30 % [5] and they are mostly low-
grade, easy to separate and do not require a lengthy
adhesiolysis [6].
Some known risk factors for adverse histopathological
outcome, such as distance to the nearest bowel resection
plane and failure to use a pathology template were not
available in the DSCA database [8]. The pathology tem-
plate for colorectal cancer was introduced in the Nether-
lands in 2009 and is generally used.
Prior abdominal surgery was not specified in the data-
base except for the ‘anatomical location’. Particularly,
magnitude (i.e., laparoscopic or minimal invasive
approach) of the previous operations and intra-abdominal
complications, e.g., postoperative peritonitis could not be
assessed. Differences in results between open and minimal
invasive prior surgery is expected as there is increasing
evidence for a lower risk of adhesion-related complications
after laparoscopic surgery [20]. Postoperative peritonitis
may render a minimal invasive operation into a very
adhesiogenic surgical procedure. In our own series of
consecutive elective colorectal operations 15 % of patients
who needed adhesiolysis had suffered from previous intra-
abdominal infection [6]. The lack of specific information
on prior surgery does not make the negative effect of prior
abdominal surgery on outcome of colorectal cancer surgery
less plausible. At most, we can assume that the negative
impact is greater when prior abdominal operations are
major. Eight-two percent of patients with prior urogenital
operations were women and diagnostic laparoscopy and
laparoscopic tubal ligation were probably the most com-
mon procedures. Female gender and a minimally adhe-
siogenic procedure in history may explain the association
of prior urogenital procedures with a larger circumferential
margin in rectal resection.
Long-term oncological outcome, overall, and disease-
free survival are not available in the DSCA database.
However, previous studies have shown that an inadequate
number of lymph nodes evaluated is associated with an
impaired outcome [21, 22], and CRM positivity increases
local recurrence risk [23]. Additionally, the higher inci-
dence of postoperative complications might worsen long-
term oncological outcome [24].
With higher life-expectancy and advances in surgical
technique the incidence of repeat abdominal surgery has
increased. Since adhesion formation is a possible reason for
our findings, routine use of anti-adhesive barriers particu-
larly in initial colorectal and hepatobiliary surgery could
potentially benefit outcome of reoperations in the same
anatomical areas. In a recent systematic review, we showed
that hyaluronate carboxymethylcellulose has the potential
to alleviate the incidence of adhesion-related complications
in colorectal surgery [25]. Also in two-stage liver surgery
hyaluronate carboxymethylcellulose was shown to reduce
operation time [26]. The potentially beneficial effect of
anti-adhesives on histopathological results of oncological
resections should be taken into account in future studies on
adhesion prevention.
This present study addresses, the negative effect of prior
abdominal surgery on the outcome of colorectal cancer
surgery. Surgeons should be aware of this effect when
performing an oncological resection in patients with
abdominal surgery in history to dissect the right planes and
obtain sufficient amounts of lymph nodes not compromis-
ing the extent of resection. The completeness and quality of
preoperative patient informed consent may benefit from the
results of this study.
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